Literature DB >> 2809509

Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.

J Bauer1, T M Bauer, T Kalb, T Taga, G Lengyel, T Hirano, T Kishimoto, G Acs, L Mayer, W Gerok.   

Abstract

IL-6 is a cytokine with pleiotropic biological functions, including induction of the hepatic acute phase response and differentiation of activated B cells into Ig-secreting plasma cells. We found that human peripheral blood monocytes express the IL-6-R, which is undetectable on the large majority of lymphocytes of healthy individuals. Stimulation of monocytes by endotoxin or IL-1 causes a rapid downregulation of IL-6-R mRNA levels and a concomitant enhancement of IL-6 mRNA expression. IL-6 itself was found to suppress the IL-6-R at high concentrations. A gradual decrease of IL-6-R mRNA levels was observed along in vitro maturation of monocytes into macrophages. We show that downregulation of IL-6-R mRNA levels by IL-1 and IL-6 is monocyte specific, since IL-6-R expression is stimulated by both IL-1 and IL-6 in cultured human primary hepatocytes. Our data indicate that under noninflammatory conditions, monocytes may play a role in binding of trace amounts of circulating IL-6. Repression of monocytic IL-6-R and stimulation of hepatocytic IL-6-R synthesis may represent a shift of the IL-6 tissue targets under inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809509      PMCID: PMC2189492          DOI: 10.1084/jem.170.5.1537

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  59 in total

1.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Repression of alpha 2-macroglobulin and stimulation of alpha 1-proteinase inhibitor synthesis in human mononuclear phagocytes by endotoxin.

Authors:  U Ganter; J Bauer; C Schulz-Huotari; P J Gebicke-Haerter; H Beeser; W Gerok
Journal:  Eur J Biochem       Date:  1987-11-16

Review 3.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

4.  The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.

Authors:  J Van Damme; M De Ley; J Van Snick; C A Dinarello; A Billiau
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

5.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

6.  High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.

Authors:  P G Coulie; A Vanhecke; J Van Damme; S Cayphas; P Poupart; L De Wit; J Content
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

7.  B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells.

Authors:  R D Garman; K A Jacobs; S C Clark; D H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  Purification and characterization of human fibroblast-derived hybridoma growth factor identical to T-cell-derived B-cell stimulatory factor-2 (interleukin-6).

Authors:  J Van Damme; S Cayphas; J Van Snick; R Conings; W Put; J P Lenaerts; R J Simpson; A Billiau
Journal:  Eur J Biochem       Date:  1987-11-02

9.  Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression.

Authors:  T Taga; Y Kawanishi; R R Hardy; T Hirano; T Kishimoto
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene.

Authors:  K Yasukawa; T Hirano; Y Watanabe; K Muratani; T Matsuda; S Nakai; T Kishimoto
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  25 in total

1.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.

Authors:  J Tanner; G Tosato
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 3.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

Review 4.  Cytokines.

Authors:  H Holtmann; K Resch
Journal:  Naturwissenschaften       Date:  1995-04

5.  Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle.

Authors:  J Bauer; F Hohagen; T Ebert; J Timmer; U Ganter; S Krieger; S Lis; E Postler; U Voderholzer; M Berger
Journal:  Clin Investig       Date:  1994-03

6.  Profile of soluble cytokine receptors in Crohn's disease.

Authors:  T Gustot; A Lemmers; E Louis; C Nicaise; E Quertinmont; J Belaiche; S Roland; A Van Gossum; J Devière; D Franchimont
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

7.  Apoptosis resistance in endometriosis.

Authors:  Ali Salmassi; Bengi Acar-Perk; Andreas G Schmutzler; Kerstin Koch; Frank Püngel; Walter Jonat; Liselotte Mettler
Journal:  Bioimpacts       Date:  2011-08-06

8.  The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation.

Authors:  U Trefzer; M Brockhaus; H Lötscher; F Parlow; A Budnik; M Grewe; H Christoph; A Kapp; E Schöpf; T A Luger
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.

Authors:  Thanh-Thuy T Le; Harry Karmouty-Quintana; Ernestina Melicoff; Thanh-Truc T Le; Tingting Weng; Ning-Yuan Chen; Mesias Pedroza; Yang Zhou; Jonathan Davies; Kemly Philip; Jose Molina; Fayong Luo; Anuh T George; Luis J Garcia-Morales; Raquel R Bunge; Brian A Bruckner; Matthias Loebe; Harish Seethamraju; Sandeep K Agarwal; Michael R Blackburn
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

10.  Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.

Authors:  Helen M McGettrick; Emily Smith; Andrew Filer; Stephen Kissane; Michael Salmon; Christopher D Buckley; G Ed Rainger; Gerard B Nash
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.